Aytu BioScience (AYTU)

2.67 +0.06 (2.30%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/8/18 *Est.)

Latest Headlines

Form S-1/A AYTU BIOSCIENCE, INC September 25, 2018 4:13 PM - SEC Filing Aytu BioScience (AYTU) Reports Publication of Manuscript Summarizing Results from the Ongoing Natesto Spermatogenesis Study September 17, 2018 8:27 AM - StreetInsider Form 8-K AYTU BIOSCIENCE, INC For: Sep 17 September 17, 2018 8:08 AM - SEC Filing Aytu BioScience Announces Publication of Manuscript Summarizing Results from the Ongoing Natesto(R) Spermatogenesis Study September 17, 2018 8:07 AM - StreetInsider Acerus Announces Publication of Manuscript Reporting Early Data from Partner-Sponsored Natesto® Spermatogenesis Study September 17, 2018 7:01 AM - BizWire Form S-1 AYTU BIOSCIENCE, INC September 7, 2018 5:24 PM - SEC Filing Form 10-K AYTU BIOSCIENCE, INC For: Jun 30 September 6, 2018 4:34 PM - SEC Filing Form 8-K AYTU BIOSCIENCE, INC For: Sep 06 September 6, 2018 4:07 PM - SEC Filing Natesto(R) Q4 Revenue Increases 178% Sequentially; Q4 Product Revenue Increases 52% Sequentially September 6, 2018 4:04 PM - StreetInsider Form 8-K AYTU BIOSCIENCE, INC For: Aug 30 August 30, 2018 8:31 AM - SEC Filing Aytu BioScience to Report Fiscal Fourth Quarter 2018 Results and Business Update August 30, 2018 8:09 AM - StreetInsider Aytu BioScience (AYTU) Reports Accelerated U.S. Launch of ZolpiMist August 13, 2018 9:35 AM - StreetInsider Aytu BioScience Announces Accelerated Launch of ZolpiMist(TM) in the U.S. August 13, 2018 9:31 AM - StreetInsider Aytu BioScience Announces Accelerated Launch of ZolpiMis(TM) in the U.S. August 13, 2018 8:06 AM - StreetInsider Form 8-K AYTU BIOSCIENCE, INC For: Aug 10 August 10, 2018 4:35 PM - SEC Filing Aytu BioScience (AYTU) Announces Effectiveness of 1-for-20 Reverse Stock Split on August 10 at 4:30 pm August 10, 2018 8:08 AM - StreetInsider Aytu BioScience Announces Effectiveness of 1-for-20 Reverse Stock Split August 10, 2018 8:07 AM - StreetInsider Aytu BioScience (AYTU) Reports Enrollment of First 20-Patients in Natesto Spermatogenesis Study July 17, 2018 8:12 AM - StreetInsider Aytu BioScience Announces Enrollment of First Twenty Patients in the Natesto(R) Spermatogenesis Study July 17, 2018 8:07 AM - StreetInsider Aytu BioScience Announces 7 Presentations of Clinical Findings for its Proprietary MiOXSYS(R) System at the 34th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) July 10, 2018 8:10 AM - StreetInsider Form 8-K AYTU BIOSCIENCE, INC For: Jun 27 July 2, 2018 6:31 AM - SEC Filing Full Article List